Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
29.09
Dollar change
-0.35
Percentage change
-1.19
%
IndexRUT P/E- EPS (ttm)-8.37 Insider Own3.85% Shs Outstand75.71M Perf Week-3.58%
Market Cap2.23B Forward P/E- EPS next Y-4.90 Insider Trans-1.29% Shs Float73.66M Perf Month3.16%
Income-626.60M PEG- EPS next Q-1.29 Inst Own110.52% Short Float14.78% Perf Quarter-0.95%
Sales937.82M P/S2.38 EPS this Y26.07% Inst Trans1.91% Short Ratio10.90 Perf Half Y25.01%
Book/sh-10.81 P/B- EPS next Y20.75% ROA-34.73% Short Interest10.89M Perf Year-35.53%
Cash/sh11.44 P/C2.54 EPS next 5Y-9.51% ROE- 52W Range17.53 - 59.84 Perf YTD5.55%
Dividend Est.- P/FCF- EPS past 5Y-24.94% ROI- 52W High-51.39% Beta0.66
Dividend TTM- Quick Ratio1.97 Sales past 5Y29.08% Gross Margin69.28% 52W Low65.94% ATR (14)1.59
Dividend Ex-Date- Current Ratio2.02 EPS Y/Y TTM-7.52% Oper. Margin-37.26% RSI (14)50.13 Volatility5.08% 6.36%
Employees995 Debt/Eq- Sales Y/Y TTM34.20% Profit Margin-66.81% Recom2.93 Target Price29.08
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q12.28% Payout- Rel Volume0.81 Prev Close29.44
Sales Surprise-2.51% EPS Surprise-1390.59% Sales Q/Q83.41% EarningsFeb 29 AMC Avg Volume999.29K Price29.09
SMA20-3.24% SMA504.19% SMA200-3.89% Trades Volume807,280 Change-1.19%
Date Action Analyst Rating Change Price Target Change
Dec-19-23Downgrade Morgan Stanley Equal-Weight → Underweight $28
Dec-08-23Initiated Wells Fargo Overweight $37
Oct-30-23Upgrade Oppenheimer Perform → Outperform $165
Oct-27-23Downgrade Citigroup Neutral → Sell $29 → $17
Oct-06-23Downgrade Truist Buy → Hold $45 → $25
Sep-18-23Downgrade Citigroup Buy → Neutral $55 → $28
Sep-15-23Downgrade Raymond James Outperform → Underperform
Mar-17-23Initiated SVB Securities Market Perform $48
Dec-14-22Initiated Goldman Sell $35
Sep-12-22Initiated Jefferies Buy $62
Today 08:30AM
Mar-25-24 10:00AM
Mar-20-24 02:00PM
Mar-19-24 07:30AM
Mar-02-24 08:56AM
06:51AM Loading…
Mar-01-24 06:51AM
Feb-29-24 06:00PM
05:20PM
04:33PM
04:30PM
04:05PM
Feb-27-24 05:20PM
Feb-26-24 09:16AM
Feb-22-24 04:30PM
Feb-15-24 08:00AM
10:00AM Loading…
Feb-13-24 10:00AM
Feb-11-24 01:45AM
Jan-26-24 04:06PM
11:45AM
10:18AM
Jan-25-24 04:51PM
04:20PM
04:05PM
Jan-24-24 07:02PM
Jan-12-24 01:02AM
Jan-08-24 09:26AM
Jan-03-24 08:00AM
Dec-20-23 09:41AM
Dec-15-23 05:01PM
Dec-14-23 04:30PM
04:15PM Loading…
Dec-05-23 04:15PM
Nov-14-23 03:58PM
Nov-03-23 04:30PM
Oct-30-23 09:03AM
Oct-27-23 11:22AM
10:01AM
08:33AM
07:15AM
02:38AM
Oct-26-23 07:30PM
06:10PM
05:30PM
04:25PM
04:05PM
Oct-24-23 10:00AM
Oct-19-23 07:02PM
10:01AM
08:00AM
Oct-16-23 04:30PM
Oct-11-23 08:07AM
Oct-06-23 09:42AM
Sep-29-23 11:18AM
Sep-28-23 05:15PM
04:42PM
04:30PM
Sep-25-23 03:18AM
Sep-20-23 04:00AM
Sep-19-23 06:46AM
Sep-15-23 04:04PM
09:28AM
06:00AM
Sep-12-23 08:00AM
Sep-07-23 07:33PM
08:00AM
08:00AM
Aug-30-23 08:00AM
Aug-28-23 08:00AM
Aug-25-23 01:38PM
Aug-04-23 01:24PM
Aug-03-23 09:30PM
05:25PM
04:14PM
04:01PM
Jul-21-23 09:30AM
Jul-20-23 08:00AM
Jul-19-23 04:30PM
Jul-18-23 04:30PM
Jul-17-23 04:30PM
Jul-11-23 12:00PM
Jun-30-23 10:18AM
Jun-29-23 04:30PM
09:18AM
Jun-28-23 07:41AM
Jun-21-23 04:24PM
07:31AM
07:12AM
07:00AM
Jun-15-23 04:30PM
Jun-02-23 08:00AM
May-31-23 06:05AM
May-25-23 10:32AM
May-24-23 04:06PM
12:48PM
12:33PM
May-23-23 05:36PM
04:07PM
04:05PM
May-18-23 12:59PM
May-17-23 04:02PM
12:28PM
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boulding Mark ElliottEXEC. VP AND CLOJan 30 '24Sale27.2579421,63771,189Feb 01 04:17 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 30 '24Sale27.2561816,84161,202Feb 01 04:18 PM
Pauwels EricCHIEF BUSINESS OFFICERJan 30 '24Sale27.253669,97444,181Feb 01 04:16 PM
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICERJan 30 '24Sale27.253188,66635,528Feb 01 04:15 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 30 '24Sale27.25287633,706Feb 01 04:18 PM
Jacobson Allan StevenDirectorJan 22 '24Option Exercise27.0510,000270,50022,348Jan 24 04:30 PM
Jacobson Allan StevenDirectorJan 22 '24Sale27.3810,000273,80412,348Jan 24 04:30 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERJan 09 '24Sale29.015,443157,928160,475Jan 10 04:08 PM
Pauwels EricCHIEF BUSINESS OFFICERJan 09 '24Sale29.012,06559,91644,547Jan 10 04:09 PM
Boulding Mark ElliottEXEC. VP AND CLOJan 09 '24Sale29.011,93856,23171,983Jan 10 04:04 PM
Utter Christine MarieSVP, FINANCE & CAOJan 09 '24Sale29.011,65347,96135,846Jan 10 04:11 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 09 '24Sale29.011,52144,13261,820Jan 10 04:03 PM
Golden Lee ScottCHIEF MEDICAL OFFICERJan 09 '24Sale29.011,22535,54337,914Jan 10 04:06 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 09 '24Sale29.011002,9013,734Jan 10 04:03 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERJan 08 '24Sale28.642,23764,068165,918Jan 10 04:08 PM
Pauwels EricCHIEF BUSINESS OFFICERJan 08 '24Sale28.641,56944,93746,612Jan 10 04:09 PM
Boulding Mark ElliottEXEC. VP AND CLOJan 08 '24Sale28.641,45741,72973,921Jan 10 04:04 PM
SCHMERTZLER MICHAELDirectorJan 08 '24Sale27.811,50041,715115,266Jan 10 04:10 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 08 '24Sale28.641,23635,39963,341Jan 10 04:03 PM
Utter Christine MarieSVP, FINANCE & CAOJan 08 '24Sale28.641,18834,02537,499Jan 10 04:11 PM
Golden Lee ScottCHIEF MEDICAL OFFICERJan 08 '24Sale28.6477522,19639,139Jan 10 04:06 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 08 '24Sale28.64531,5183,834Jan 10 04:03 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERJan 05 '24Sale27.1510,107274,393168,155Jan 09 04:29 PM
Gravier PierreCHIEF FINANCIAL OFFICERDec 12 '23Buy25.817,700198,73633,700Dec 14 04:38 PM
Young AlethiaDirectorSep 06 '23Option Exercise27.8511,666324,89816,067Sep 08 04:02 PM
Young AlethiaDirectorSep 06 '23Sale39.8611,666464,9729,067Sep 08 04:02 PM
SCHMERTZLER MICHAELDirectorJun 07 '23Sale44.861,00044,860116,766Jun 09 04:03 PM
Reeve EmmaDirectorMay 23 '23Option Exercise33.382,65288,5208,602May 24 04:12 PM
Reeve EmmaDirectorMay 23 '23Sale59.532,652157,8857,200May 24 04:12 PM
Reeve EmmaDirectorMay 22 '23Option Exercise33.377,116237,48411,148May 24 04:12 PM
Reeve EmmaDirectorMay 22 '23Sale59.537,116423,6307,200May 24 04:12 PM
Pauwels EricCHIEF BUSINESS OFFICERMay 22 '23Sale59.012,013118,79147,553May 23 04:05 PM
Pauwels EricCHIEF BUSINESS OFFICERMay 19 '23Sale58.966,403377,49149,566May 23 04:05 PM
Pauwels EricCHIEF BUSINESS OFFICERMay 18 '23Sale58.7178846,26755,969May 19 04:04 PM
Pauwels EricCHIEF BUSINESS OFFICERMay 17 '23Sale58.508,048470,82256,757May 19 04:04 PM
Jacobson Allan StevenDirectorMay 11 '23Option Exercise10.8523,000249,55035,348May 12 04:08 PM
Jacobson Allan StevenDirectorMay 11 '23Sale55.0823,0001,266,93012,348May 12 04:08 PM
Utter Christine MarieSVP, FINANCE & CAOApr 21 '23Option Exercise33.024,692154,93042,380Apr 25 04:09 PM
Utter Christine MarieSVP, FINANCE & CAOApr 21 '23Sale55.064,692258,32638,059Apr 25 04:09 PM
Reeve EmmaDirectorApr 21 '23Sale55.054,328238,2587,200Apr 25 04:08 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERApr 18 '23Sale52.041,21163,025102,645Apr 20 04:05 PM
Pauwels EricCHIEF BUSINESS OFFICERApr 18 '23Sale52.0473238,09664,805Apr 20 04:07 PM
Boulding Mark ElliottEXEC. VP AND CLOApr 17 '23Option Exercise30.8661,9231,910,944134,009Apr 19 04:09 PM
SOUTHWELL DAVID PDirectorApr 17 '23Option Exercise18.0111,429205,83621,929Apr 19 04:11 PM
Boulding Mark ElliottEXEC. VP AND CLOApr 17 '23Sale51.4261,9233,183,83075,378Apr 19 04:09 PM
SOUTHWELL DAVID PDirectorApr 17 '23Sale51.0311,429583,18710,500Apr 19 04:11 PM
SOUTHWELL DAVID PDirectorMar 31 '23Option Exercise18.012,57146,30413,071Apr 04 04:07 PM
SOUTHWELL DAVID PDirectorMar 31 '23Sale50.052,571128,67210,500Apr 04 04:07 PM
Utter Christine MarieSVP, FINANCE & CAOMar 29 '23Option Exercise40.454,688189,63042,747Mar 31 04:21 PM
Utter Christine MarieSVP, FINANCE & CAOMar 29 '23Sale47.794,688224,04438,059Mar 31 04:21 PM